Figures
Abstract
Background
The Myelin Basic Protein (MBP) gene is essential for myelin sheath formation in the central nervous system. Coding and noncoding single-nucleotide polymorphisms (SNPs) can impair the protein structure and function, contributing to demyelinating diseases exemplified by multiple sclerosis. This study aimed to assess the impact of SNPs in the MBP gene on protein structure and function.
Methods
We employed a comprehensive approach to investigate the impact of both noncoding and coding SNPs of the MBP gene. Initially, we utilized RegulomeDB to assess the regulatory roles of SNPs located in the 3′ untranslated regions (3′ UTRs). Subsequently, we examined the influence of the 3’ UTR SNPs on microRNA (miRNA) binding sites using PolymiRTS. Furthermore, we analyzed the functional 3′ UTR SNPs using RNAfold to evaluate their impact on RNA structure. To predict deleterious nonsynonymous SNPs (nsSNPs), various bioinformatics tools, including SIFT, PolyPhen-2, PROVEAN, META-SNP, ESNPs&GO, PANTHER, and AlphaMissense, were employed. Protein stability was assessed using I-Mutant2.0, MUpro, and DDMut. Structural modeling was performed with AlphaFold, and both wild-type and mutant proteins were visualized in UCSF ChimeraX. Conservation analysis was conducted using the ConSurf tool, and protein interaction networks were explored using the STRING database.
Results
Eight noncoding SNPs were identified as potential regulatory SNPs, affecting the miRNA binding sites. Moreover, three nsSNPs, rs1971676214 (D173E), rs1242552448 (D173H), and rs772570115 (G176W), were consistently predicted to be pathogenic and to destabilize the protein structure. These variants were located in highly conserved sites and disrupted hydrogen bonds. STRING analysis revealed interactions between MBP and other myelin-related, immune, and signaling proteins, linking it to CNS and autoimmune pathways.
Citation: Alwabran AI, Aldoseri GM, Aldoseri GM, Mohager SO, Aldoseri MM, Kamal E (2026) Decoding the genetic basis of demyelination: Prediction of potential pathogenic coding and regulatory noncoding MBP SNPs in multiple sclerosis. PLoS One 21(5): e0347598. https://doi.org/10.1371/journal.pone.0347598
Editor: Srinivas Mummidi, Texas A&M University-San Antonio, UNITED STATES OF AMERICA
Received: November 5, 2025; Accepted: April 4, 2026; Published: May 21, 2026
Copyright: © 2026 Alwabran et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files or at https://doi.org/10.5281/zenodo.19499761.
Funding: This study is supported via funding from Prince Sattam bin Abdulaziz University Grant Number: 2025/03/34494.
Competing interests: The authors have declared that no competing interests exist.
1. Introduction
The Myelin Basic Protein (MBP) gene plays a critical role in the central nervous system (CNS) by encoding a protein that contributes to the assembly, compaction, and stabilization of the myelin sheath. This multilayered membrane protein insulates axons, enabling rapid saltatory nerve conduction and maintaining the efficiency of neural signaling [1, 2]. The MBP gene is located on chromosome 18q22 and spans approximately 45 kilobases, containing seven exons [3, 4]. Its expression is primarily restricted to oligodendrocytes within the CNS, although lower levels are also observed in Schwann cells of the peripheral nervous system [1]. MBP is characterized by its high basicity and intrinsically disordered structure, properties that facilitate its interaction with negatively charged membrane surfaces and cytoskeletal elements [2]. Through alternative splicing, the MBP gene generates multiple isoforms with distinct functional properties contributing to the structural integrity and plasticity of the myelin sheath [5]. Among these are the classic MBP isoforms predominant in the CNS and the Golli-MBP variants, which are expressed in immune-related tissues, notably within the thymus and spleen, suggesting additional immunological functions for this protein [6, 7]. Disruption of the MBP gene expression or its structural integrity has been closely linked to demyelinating diseases, particularly multiple sclerosis (MS), a chronic autoimmune disorder characterized by immune-mediated degradation of the myelin sheath, resulting in neurological dysfunction [8]. MBP is recognized as a major autoantigen in MS, with its degradation products frequently detected in the cerebrospinal fluid of individuals affected by the disease. Experimental studies have demonstrated that immunodominant fragments of MBP can provoke T-cell-mediated demyelination, emphasizing its pivotal role in the pathogenesis of MS [9]. The untranslated regions (UTRs) of a gene play an essential role in regulating its expression. 3′UTR governs mRNA stability, subcellular localization to myelin sheaths, and local translation in oligodendrocyte processes, largely through interactions with RNA-binding proteins and microRNAs (miRNAs) [10–12]. Experimental studies demonstrate that proper function of the MBP 3′ UTR is critical for mRNA transport and translational control in oligodendrocytes, with disruptions leading to altered protein expression [13]. SNPs in the UTR may therefore contribute to dysregulated MBP expression and increase susceptibility to demyelinating disorders. Nonsynonymous single-nucleotide polymorphisms (nsSNPs) represent the subset of coding variants that can directly alter amino acid sequence and protein function and represent the most prevalent form of genetic variation within the human genome. These variations have potential to substantially impact protein structure and function [14,15]. Several nsSNPs within the MBP gene have been associated with susceptibility to MS and variability in disease progression [8]. Despite these findings, the functional implications of numerous MBP nsSNPs remain largely unexplored, representing a significant gap in the understanding of the genetic basis of demyelinating disorders. Therefore, characterizing these genetic variations is essential for enhancing diagnostic, prognostic, and therapeutic strategies for demyelinating diseases. Bioinformatics provides a reliable, time-efficient, and cost-effective approach to predict the potential pathogenicity of SNPs by assessing their effects on gene expression, protein stability, structure, and interactions [16]. Computational analyses enable the prioritization of potential disease-causing variants for experimental validation, facilitating the identification of molecular targets implicated in disease development. In the present study, a comprehensive bioinformatics approach was applied to analyze both coding and 3′ UTR-noncoding SNPs within the MBP gene. The objective was to identify variants with potential effects on miRNA binding sites, protein structure, and function, thereby providing a foundation for future experimental research into the genetic mechanisms underlying myelin dysfunction and autoimmune neurodegeneration. To our knowledge, this study represents the first in silico investigation to systematically assess both noncoding and coding MBP variants using combined analyses of structural, regulatory, and stability effects.
2. Materials and methods
2.1. Analysis of MBP gene expression
Using the GTEx Database The Genotype-Tissue Expression (GTEx) database provides comprehensive transcriptomic data from a wide range of normal human tissues, enabling the assessment of tissue-dependent expression variability [17]. The GTEx database v8 (https://gtexportal.org/home/) was accessed on 29 September 2025 to analyze the tissue-specific expression profile of the MBP gene.
2.2. Protein information retrieval
Data for the human MBP gene were obtained from the National Center for Biotechnology Information (NCBI) website (https://www.ncbi.nlm.nih.gov/, accessed on May 14, 2025). Information on SNPs, including SNP IDs for the MBP gene, was retrieved from the NCBI dbSNP database (https://www.ncbi.nlm.nih.gov/datasets/gene/4155/) (accessed on 14 May 2025).
Protein sequence and annotation for MBP were obtained from the UniProt database (UniProtKB; https://www.uniprot.org), entry P02686, accessed on 14 May 2025. UniProt is a curated resource of protein sequences and functional information [18]. (https://www.uniprot.org/, accessed May 14, 2025).
2.3. Retrieval of UTR SNPs and annotation using regulomeDB
RegulomeDB v 2.2 (https://regulomedb.org/regulome-search/) is an integrative bioinformatics platform that systematically annotates non-coding UTR SNPs by consolidating high-throughput genomic, epigenomic, and transcriptional data from major consortia, including ENCODE and GEO. This database facilitates the functional interpretation of variants within regulatory elements, thereby identifying SNPs with potential roles in the modulation of gene expression. RegulomeDB assigns scores to SNPs to facilitate the identification of functional SNPs [19, 20]. The rank scores in RegulomeDB range from 1 to 7 (subcategorized into 1a–f, 2a–c, 3a, 3b, 4, 5, 6, and 7), wherein lower scores denote a higher likelihood of functional regulatory activity [21]. NCBI was accessed for the retrieval of 3′ UTR SNPs. Functional annotation and scoring of 3′ UTR SNPs of MBP were performed through RegulomeDB, and the scores of MBP non-coding SNPs were determined based on their corresponding rs identifiers. RegulomeDB was accessed on 2nd June 2025
2.4. Determination of 3′ UTR SNPs eQTLs
We used the GTEx database v8 to study the expression quantitative trait loci (eQTLs) of 3′ UTR SNPs,which were classified as functional in RegulomeDB. The portal identifies the associations between genetic variants and gene expression across tissues using a linear regression model implemented in the GTEx pipeline to test associations between variants and gene expression, adjusting for covariates specified by GTEx. Violin plots are generated to visualize gene expression levels across different genotypes of a specific variant within a selected tissue. The plot displays both the distribution and median expression for each genotype group, along with the corresponding p-value < 0.05, indicating the significant association. There is no additional multiple-testing correction performed in this study. GTEx portal accessed on 12 January 2026.
2.5. The functional impact of 3′ UTR SNPs on microRNA binding affinity
The correlation between 3′ UTR SNPs and miRNA binding sites was analyzed through the PolymiRTS Database v3.0 (https://compbio.uthsc.edu/miRSNP/). This computational resource systematically detects noncoding SNPs positioned within miRNA seed sequences or their complementary recognition sites. It predicts potential alterations in miRNA–mRNA interaction dynamics caused by these genetic variations [22]. miRNAs exert post-transcriptional control over gene expression by promoting translational inhibition or mRNA decay and sequence alterations within miRNA genes or their corresponding target regions. The PolymiRTS algorithm categorizes SNP-related effects into four distinct groups: D (loss of a conserved binding site), N (loss of a non-conserved site), C (emergence of a novel site), and O (undefined ancestral allele status). The polymiRTS database provides extensive insights into sequence conservation, ancestral versus derived alleles, and variations in context- dependent scores, thereby enabling a comprehensive evaluation of the functional regulatory implications of each identified 3′ UTR SNP. PolymiRTS Database was accessed on 25 June 2025
2.6. Effect of 3′ UTR SNPs on the secondary structure of mRNA
mRNA secondary structure predictions for 3′UTR variants were generated using RNAfold from the ViennaRNA Package v 2 (http://rna.tbi.univie.ac.at), accessed on 20 May 2025. RNAfold predicts minimum free-energy (MFE)structures and base-pairing probabilities for RNA sequences. It utilizes thermodynamic principles and dynamic programming to determine the most stable folding conformation. MFE postulates that an RNA molecule folds into the structure that minimizes its overall Gibbs free energy (ΔG) under defined conditions [23]. The 3′ UTR SNPs annotated with RegulomeDB scores of ≤2b, indicating potential disruption or facilitation of novel miRNA binding sites, were prioritized for downstream analysis using the RNAfold server. The MFE values and the corresponding mRNA secondary structures were calculated using wild-type and variant sequences obtained from NCBI to evaluate the structural impact of each 3′ UTR SNP. RNAfold was accessed on 5 July 2025.
2.7. Assessment of deleterious nsSNPs and their predicted phenotypes
To predict deleterious nsSNPs, seven different computational tools were employed. The bioinformatics tools used in the prediction of the nsSNPs effect, and their cutoff Values were summarized in Table 1.
Sorting Intolerant From Tolerant (SIFT) (http://sift.bii.a-star.edu.sg/,) predicts the impact of amino acid substitutions on protein function. The nsSNP IDs were collected from NCBI databases and submitted to SIFT for analysis. nsSNPs with scores ranging from 0.0 to 0.04 were classified as damaging, whereas those with scores from 0.05 to 1.0 were considered benign [25]. PolyPhen 2.0 (http://genetics.bwh.harvard.edu/pph2/,). It evaluates the potential impact of nsSNPs by analyzing sequence conservation, structural features, and functional domains of the protein. The tool categorizes nsSNPs as “benign,” “possibly damaging,” or “Probably damaging” based on their likelihood to affect protein function [26]. Deleterious nsSNPs predicted in SIFT were used as input in PolyPhen 2.0 to assess the possible effects of amino acid substitutions on protein function. Protein Variation Effect Analyzer (PROVEAN) (https://www.jcvi.org/research/provean/,) is a computational too used to predict the effect of amino acid substitutions or insertions/deletions on protein function. Variants scoring −2.5 or lower are classified as deleterious, while those with scores above −2.5 are considered neutral [27]. To evaluate the potential pathogenicity of the selected nsSNPs, we utilized the META-SNP tool (https://snps.biofold.org/meta-snp/pages/methods.html,), a consensus- based web server that integrates the outputs of several individual nsSNP effect prediction tools [28]. The ESNPs&GO tool (https://esnpsandgo.biocomp.unibo.it/,) was used to predict the pathogenicity of nsSNPs. This method integrates protein sequence embeddings generated by advanced protein language models (ProtTrans T5 and Anc2Vec) along with Gene Ontology (GO) annotations to assess the functional impact of amino acid substitutions. The tool applies a support vector machine (SVM) classifier to provide a probability score indicating whether a variant is likely disease-associated or neutral [29]. The Protein Analysis Through Evolutionary Relationships (PANTHER) tool (http://pantherdb.org/,) evaluates evolutionary conservation using the PANTHER PSEP (Position-Specific Evolutionary Preservation) module, which was used for variant effect prediction, rather than the broader PANTHER database for GO enrichment. The PSEP estimates the evolutionary preservation time of amino acid positions to infer variant impact [30]. Based on the PSEP value, nsSNPs are categorized as “probably benign” if conserved for less than 200 million years, “possibly damaging” if less than 450 million years but more than 200 million years, and “probably damaging” if conserved for 450 million years or more, according to the PANTHER-PSEP server’s default classification.
2.8. Computational prediction of missense variant pathogenicity using AlphaMissense
AlphaMissense (https://alphamissense.hegelab.org/search,) is a deep learning-based method, designed to classify nsSNPs as benign or pathogenic by integrating structural and functional features of proteins for cell survival. The tool provides pathogenicity scores ranging from 0 to 1, where high scores indicate a higher probability of pathogenicity. Based on the generated scores, nsSNPs were classified as likely pathogenic or likely benign [31]. We used AlphaMissense to predict the pathogenicity of missense variants in the MBP gene.
2.9. Effect of MBP nsSNPs on protein stability
I-Mutant 2.0 (https://folding.biofold.org/i-mutant/i-mutant2.0.html), a neural network-based tool that was used to predict the effect of nsSNPs on protein stability by estimating changes in ∆∆G. Protein sequences were input that we used to generate stability change predictions with associated confidence scores [32]. MUpro (http://mupro.proteomics.ics.uci.edu), a suite of machine-learning techniques designed to assess the effect of individual nsSNPs on protein stability. It combines SVM and neural networks to classify whether stability increases or decreases and provides a ∆∆G prediction with an associated confidence score ranging from −1–11 [33]. DDMut (https://biosig.lab.uq.edu.au/ddmut/,) utilizes deep learning method to rapidly and accurately predict changes in ∆∆G for both single and multiple mutations [34].
2.10. Population allele frequency and clinical annotation analyses
To study the Population allele frequency, we used the gnomAD v4.1.0 (https://gnomad.broadinstitute.org/). The input was the gene name MBP, and global allele frequencies and functional annotations of all MBP variants [38]. Clinical annotations for MBP variants were checked using the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/), a weekly updated public archive of interpretations of the clinical significance of human genetic variants, aggregated from multiple clinical and research submitters analysis [39]. GnomAD and ClinVar were accessed on 10 January 2026.
2.11. Computational analysis of evolutionary conservation
We utilized the ConSurf server (https://consurf.tau.ac.il,) to analyze the evolutionary conservation of nsSNPs within the protein sequence. This analysis identified highly conserved residues and categorized them as either exposed or buried [35]. The FASTA sequence of MBP was submitted to the ConSurf server to quantitatively assess the conservation levels of individual amino acid residues.
2.12. Variant prioritization criteria
NsSNPs were prioritized using a multi-step in silico filtering strategy integrating functional, stability, and evolutionary evidence. First, all MBP nsSNPs retrieved from dbSNP were screened with SIFT, and nsSNPs with scores ≤ 0.04 were classified as deleterious and retained for further analysis, whereas those with scores ≥ 0.05 were considered tolerated and excluded. Next, the SIFT- positive variants were evaluated with PolyPhen-2 and PROVEAN; only nsSNPs predicted as “probably/possibly damaging” by PolyPhen-2 and “deleterious” by PROVEAN (score ≤ −2.5) were considered for further analysis. To refine pathogenicity, the predicted deleterious nsSNPs were subsequently analyzed using META-SNP, ESNPsGO, PANTHER-PSEP, and AlphaMissense.
Only nsSNPs consistently classified as disease-associated or likely pathogenic across these tools were retained. nsSNPs meeting these functional/pathogenic criteria were then subjected to stability prediction tools. NsSNPs predicted to decrease stability by the three tools (I-Mutant 2.0, MUpro, and DDMut) were prioritized as stability-impairing nsSNPs. nsSNPs located at positions with the highest conservation scores and classified as buried structural residues predicted in ConSurf were considered for downstream structural and interaction analyses.
2.13. Computational prediction and visualization of protein structure
We used AlphaFold (https://alphafold.ebi.ac.uk,), an advanced artificial intelligence system developed by Google DeepMind, to predict the three-dimensional structure of the MBP. AlphaFold applies deep learning to accurately model protein structures from their amino acid sequences [36]. The UniProt sequence of MBP was used as input to generate the structural model. To visualize and analyze the predicted structure, we employed UCSF ChimeraX 1.9 (https://www.rbvi.ucsf.edu/chimerax/, accessed on 2 June 2025), a versatile molecular visualization tool that supports the interactive examination of structural data, including density maps, sequence alignments, and large biomolecular complexes [40]. ChimeraX was used to map and compare amino acid substitutions between the wild-type and mutant forms of MBP.
2.14. Prediction of changes in the biological interactions between wild- type and mutant MBP protein
We used DDMut to detect the changes in the biological interactions between wild-type amino acids and neighborhood residues in comparison with mutant residues [34].
2.15. Estimation of protein-protein interactions
We used the STRING database, version 12.0 (https://string-db.org/,), to study MBP-protein interactions. This database integrates data from experiments, computational predictions, and text mining and assigns a confidence score to each interaction [37, 41]. We used MBP as the input in the protein-by-name module, selecting “Homo sapiens” as the species. Furthermore, we configured the following parameters: meaning of network edges: “evidence,” active interaction sources: “Experiments, Text Mining, Databases, expression, Neighborhood, and co-occurrence,” The minimum required interaction score is “medium confidence 0.700,” and the maximum number of interactors to display is “no more than 50 interactors.” Finally, the MBP- interacting proteins were visualized. Gene Ontology (GO) enrichment analysis for MBP-related proteins were performed using STRING. Enriched biological process, molecular function, and cellular Component terms were identified based on the statistics provided by STRING database. GO Terms with a false discovery rate (FDR) < 0.05 were considered more robust signals and considered significantly enriched.
3. Results
3.1. Tissue-specific expression analysis of MBP using GTEx
GTEx Expression analysis showed MBP is predominantly expressed in brain tissues, with the highest expression detected in the brain white matter, cerebellum, anterior cingulate cortex (BA24), and frontal cortex (BA9). Conversely, non-neural tissues, including adipose, liver, and blood, displayed minimal expression (Fig 1).
3.2. Distribution of MBP gene SNP datasets
SNPs were retrieved from NCBI In the noncoding regions; there were 2,709 within the 3′UTR (S1 Table) and 9,266 within the 5′UTR. In addition, we found 614 were nsSNPs (S2 Table), 303 were synonymous SNPs (sSNPs), and 58,685 were within intronic sequences (Fig 2). For this study, we further analyzed both noncoding 3′UTR SNPs and nsSNPs.
3.3. Scoring of 3ˊUTR SNPs on RegulomeDB
The SNPs in the 3ˊUTR were subjected to functional evaluation through the RegulomeDB server. Out of all SNPs, 1,286 in the 3ˊ UTR were found on RegulomeDB (S3.1–S3.14 Table). A sum of 194 SNPs in 3ˊ UTR were annotated as ≤ 2b by RegulomeDB, having variable RegulomeDB scores (Fig 3).
The plot shows the distribution of RegulomeDB scores for 1,286 MBP 3′UTR SNPs retrieved from the database. Lower scores (1f–2b) indicate stronger evidence for regulatory function, integrating transcription factor binding, DNase hypersensitivity, and chromatin state annotations, whereas higher scores (5–7) suggest minimal regulatory evidence. SNPs with scores of ≤ 2b were selected as functionally relevant for downstream analyses.
3.4. Determination of 3ˊUTR SNPs eQTLs of MBP
All SNPs located within the 3′ UTRs of the MBP gene and classified as functional SNPs in RegulomeDB were evaluated for eQTL effects using the GTEx portal. GTEx v8 skeletal muscle eQTLs for MBP were derived from Muscle – Skeletal RNA-seq samples (n = 816 donors), and associations were considered significant at a nominal p < 0.05 as FDR/q-values were not used for filtering. Among all evaluated 3ˊUTR variants, two SNPs, rs9199 and rs1048947, located in the 3′ UTR, had significant association with MBP gene expression in skeletal muscle tissue (Fig 4). The normalized effect size (NES) indicated regulatory effects on gene expression with p-values of 0.0000067 and 0.000020, respectively (Table 2).
The y-axis represents normalized expression values (unitless), and the black boxes indicate the median and interquartile range for each genotype group. Sample sizes for each genotype are shown in parentheses below the x-axis labels (AA/AG/GG for rs9199 and GG/GT/TT for rs1048947). Associations were considered at nominal p < 0.05 and are interpreted as exploratory eQTL signals.
3.5. Association of 3’ UTR SNPs with miRNAs
The impact of 3’ UTR SNPs, as retrieved from NCBI, on miRNA was evaluated using PolymiRTS. It identified the association of SNPs with miRNAs, along with functional impact scores. 147 SNPs were identified as disrupting the conserved region of miRNA (D score), with scores ranging from 2 to 10. Additionally, 121 SNPs facilitated the formation of de novo miRNA-binding sites, as indicated by the C score (S4 Table).We identified eight functional 3’UTR SNPs with scores ≤ 2b that either disrupt or create novel miRNA binding sites. The RegulomeDB and PolymiRTS scores are presented in Table 3.
3.6. Impact of 3ˊUTR SNPs on secondary structure of mRNA
Eight functionally relevant 3ˊUTR SNPs identified by RegulomeDB (rank ≤ 2b), which either disrupt or generate novel miRNA binding sites, were selected for further structural analysis using RNAfold to illustrate potential structural differences between alleles, and no inferential statistics were applied. Computational predictions revealed that six of the 3′ UTR variants induced alterations in the MFE and secondary structure of the mRNA, whereas the remaining two SNPs produced negligible changes in both MFE (Table 4) and mRNA conformation (Fig 5).
The colour gradient represents the base-pairing probability, where red indicates highly stable paired regions, and green to yellow denotes less stable or unpaired bases.
A total of 614 nsSNPs were initially extracted and analyzed using multiple in silico pathogenicity prediction tools. Among these, 218 variants were identified as potentially deleterious by SIFT (S5 Table) and were subsequently evaluated using two additional tools: PolyPhen-2 and PROVEAN. From this analysis, 172 nsSNPs were classified as damaging in PolyPhen-2 (S6 Table). 99 nsSNPs were predicted to be damaging by all three tools (S7 Table). These 99 potentially deleterious nsSNPs were then subjected to a second set of tools using META-SNP, ESNPs&GO, and PANTHER to assess their potential disease associations. We found that 54 nsSNPs were classified as disease-related by META-SNP (S8 Table), 17 nsSNPs by ESNPs&GO (S9 Table), and 9 by PANTHER. Ultimately, nine nsSNPs were consistently predicted as pathogenic across all six bioinformatics tools (Table 5). Further computational analyses were performed to evaluate the structural and functional consequences of these potentially disease-causing nsSNPs.
3.8. Pathogenicity assessment of MBP nsSNPs using AlphaMissense
AlphaMissense analysis was performed to predict the pathogenicity of selected MBP gene variants. The results indicated that seven out of the predicted nine deleterious nsSNPs, including the rs1971676214 (D173E), rs1242552448 (D173H), rs772570115 (G176W), rs772570115 (G176R), rs1488047563 (S174F), and rs1194494874 (S174P), showed pathogenicity scores > 0.78 and were classified as likely pathogenic. In contrast, the rs779353840 (R177H) had a pathogenicity score of 0.181, indicating that it is likely benign. One variant, rs748450291 (R177C), was classified as ambiguous with pathogenicity scores of 0.38 (Table 6).
3.9. Result of the impact of the deleterious nsSNPs on MBP protein stability
We utilized three in-silico prediction tools: I-MUTANT 2.0, MUpro, and DDMUT. The computational results demonstrated that nsSNPs rs1971676214 (D173E), rs1242552448 (D173H), and rs772570115 (G176W) exhibited a destabilizing effect on the MBP protein structure. These substitutions were consistently predicted to reduce protein stability, as evidenced by negative ΔΔG (kcal/mol) values across all tools (Table 7).
3.10. Results of population allele frequency and clinical annotation analyses
To study the Population allele frequency, we used the gnomAD database. The input was the gene name MBP, and global allele frequencies and functional annotations of all MBP SNPs were retrieved (S10 Table). We found that one prioritized MBP nsSNP, rs1971676214 (D173E), was extremely rare in the global population, including African, Latino/Admixed American, East Asian, South Asian, European (non-Finnish and Finnish), and Middle Eastern cohorts, consistent with a very rare variant. Rs1242552448 (D173H) and rs772570115 (G176W) were not reported in the gnomAD database. No ClinVar records with definitive pathogenic or likely pathogenic classifications were identified for the potentially deleterious MBP nsSNPs. These nsSNPs were unclassified and remain unannotated in the current clinical databases, indicating that their predicted deleterious effects on MBP structure and function have not yet been captured in routine clinical variant interpretation workflows.
3.11. Result of conservation analysis
The evolutionary conservation of amino acid residues in the MBP protein was evaluated using the ConSurf server. Three nsSNPs, rs1971676214 (D173E), rs1242552448 (D173H), and rs772570115 (G176W), were identified in highly conserved regions, with a conservation score of 9, the highest on ConSurf’s scale. Based on structural context, D173E, D173H, and G176W were predicted as structural residues, characterized by both high conservation and burial within the protein core (Table 8).
3.12. Protein 3D structure prediction by AlphaFold and nsSNPs visualization by Chimera X
The three-dimensional structure of the human MBP protein was predicted using the AlphaFold algorithm (Fig 6), which provides a confidence score called pLDDT (predicted Local Distance Difference Test) ranging from 0 to 100. Regions with pLDDT scores above 90 are considered highly confident, while other areas show moderate confidence (scores between 70 and 90), low confidence (50–70), or very low confidence (below 50). We studied the AlphaFold structural model of MBP. We found that positions D173 and G176 had predicted confident pLDDT scores of 76.19 and 79.12, respectively, indicating a good backbone prediction and a reliable backbone and side chain (Fig 7). The pdb structure files of the wild type (AF-P02686-F1-model_v6.pdb) and mutant proteins (D173E.pdb, D173H.pdb, and G176W.pdb) were provided in the supplementary files (S1 File for the wild-type protein, S2 File for D173E, S3 File for D173H, and S3 File for G176W). ChimeraX was used to visualize the 3D structures, displaying wild-type amino acids and the mutant residues (Fig 8).
(A)wild type amino acid at position 173(D)(left), mutant type amino acid at position 173(E)(right), (B)wild-type amino acid at position 173(D)(left), mutant-type amino acid at position 173(H)(right), (C)wild type amino acid at position 176 (G)(left)mutant type amino acid at position 176(W)(right).
3.13. Structural impact of predicted variants on hydrogen bonds
We used DDMut to predict potential alterations in hydrogen bonds as consequences of the deleterious missense variants in the MBP gene. Our results indicated that the substitutions rs1971676214 (D173E) and rs772570115 (G176W) are likely to disrupt hydrogen bond formation, which could potentially affect the local conformation and stability of the MBP protein. In contrast, rs1242552448 (D173H) was not predicted to interfere with hydrogen bonding (S11 Table). The structural impact of these variants is displayed in Fig 9.
(A)wild type amino acid at position 173(D)(left), mutant type amino acid at position 173(E)(right), (B)wild-type amino acid at position 173(D)(left), mutant-type amino acid at position 173(H)(right), (C)wild type amino acid at position 176 (G)(left)mutant type amino acid at position 176(W)(right).
3.14. MBP—protein interaction and disease association
STRING was used to analyze the wild-type MBP protein–protein interaction network and associated pathways. The network comprised 47 nodes and 178 observed edges, which is substantially higher than the 66 edges expected, with a PPI enrichment p-value < 1.0 × 10 ⁻ ¹⁶, indicating significant functional enrichment. MBP exhibited interactions with key myelin- associated proteins, including PLP1, MAG, MOG, MOBP, and CNP. MBP also interacted with transcription factors (SOX10, OLIG1, and OLIG2) and immune-related proteins, including CD4, ITGAM, and HLA class II molecules (HLA-DRA, HLA-DPB1). Additional connections were observed with cytoskeletal proteins (NEFL, GFAP), signaling molecules (MAPK1, MAPK3, SRC), and calcium-binding proteins (CALM1–CALM6) (Fig 10). We further studied the GO for MBP and its related proteins. We found that 45 interacting proteins were enriched in the Biological Process of biological regulation, which emerged as the most significantly enriched term (p-value < 0.05), encompassing the highest number of MBP-interacting proteins (Fig 11A). Within the GO Molecular Function category, protein binding was identified as the most significantly enriched function (p-value < 0.05) (Fig 11B). KEGG pathway enrichment analysis highlighted the RIG-I-like receptor signaling pathway and cytokine-cytokine receptor interaction among the most significantly enriched pathways (p-value < 0.05) (Fig 11C). Moreover, disease-gene association analysis revealed that nervous system diseases and central nervous system disorders were among the top enriched disease categories (Fig 11D).
Gene Ontology enrichment for Biological Processes (A), Gene Ontology enrichment for Molecular Functions (B), KEGG pathway enrichment analysis (C), and Enrichment of Disease-Gene Associations (D).
In the present study, a comprehensive computational approach was employed to assess the potential pathogenicity of both noncoding and coding SNPs in the MBP gene. Expression analysis using GTEx data indicated that MBP is predominantly expressed in brain tissues (Fig 1), consistent with its established role as a structural component of the myelin sheath in the CNS. This tissue-specific enrichment underscores the functional specialization of MBP in neuronal myelination and the maintenance of axonal integrity. In this study we analyzed 2,709 SNPs within the 3′UTR (S1 Table) and 614 were nsSNPs (S2 Table). We identified 194 SNPs in the 3′UTR with RegulomeDB scores ≤ 2b (Fig 3). Functional evaluation using RegulomeDB enabled a systematic assessment of these noncoding variants, highlighting their likely impact on gene regulation. SNPs with lower scores (closer to 1) are more likely to affect the binding of regulatory proteins and impact gene expression. These findings contribute to our understanding of the complex interplay between genetic variations and gene function, potentially influencing disease susceptibility or other phenotypic traits. Consistent with the GTEx analysis, two 3′UTR variants (rs9199 and rs1048947) showed association with MBP expression in skeletal muscle, with small but detectable changes in normalized expression (Fig 4). These eQTLs were identified using nominal p-value thresholds without multiple-testing correction (Table 2) and should therefore be interpreted as exploratory, hypothesis-generating signals that require replication in independent datasets and functional validation Although MBP is classically regarded as a central nervous system–restricted gene with a primary role in myelin formation, previous studies have reported MBP immunoreactivity and the presence of MBP epitopes in non-neural tissues and cell types [42, 43]. The detection of an MBP eQTL in a non-CNS tissue is notable for the complexity of tissue- specific gene regulation. Potential explanation is that neural and muscle tissues possess a shared regulatory mechanism, wherein the expression of MBP is controlled by common transcriptional mechanisms or chromatin configurations. Additionally, the muscle tissue eQTLs for MBP could represent low level expression or regulatory activity of the gene in a specific context that is not fully captured in the GTEx data. These observations support the biological credibility of low-level or context-dependent MBP expression outside the nervous system. Nevertheless, given the comparatively limited expression of MBP in non-neural tissues, this finding should be interpreted with caution. Consistent with a potential regulatory role, both rs9199 and rs1048947 had RegulomeDB score of 1f, indicating a significant effect on regulatory annotation, however, experimental validation will be necessary to establish its functional impact and biological significance. Analysis of eight functionally significant and 3′UTR SNPs from RegulomeDB (rank ≤ 2b) provided insights into their potential regulatory effects on miRNA binding sites and mRNA structure (Table 3). These SNPs were specifically evaluated using RNAfold to compare MFE and secondary structure between wild-type and mutant sequences. Six out of eight functionally significant 3′ UTR variants had a change in MFE (Table 4) and altered mRNA structure (Fig 5), with three destabilizing and three stabilizing the transcript, while the remaining two showed minimal effect. These results underscore the value of combining regulatory scoring and structural predictions to prioritize variants with potential functional significance, as alterations in mRNA conformation or miRNA binding may influence gene expression through transcriptional or post-transcriptional mechanisms. Moreover, we predicted only 3 variants, rs1971676214 (D173E), rs1242552448 (D173H), and rs772570115 (G176W), as potential deleterious nsSNPs and destabilizing the protein structure using various bioinformatics tools (Table 7). Upon studying the population allele frequency of the three predicted disease-causing nsSNPs using the gnomAD database, we found only one nsSNP, rs1971676214 (D173E), was extremely rare in the global population, consistent with very rare variation. While rs1242552448 (D173H) and rs772570115 (G176W) were not reported in the gnomAD database. The rarity of these predicted deleterious nsSNPs in gnomAD emphasizes their uncharacterized but potentially disease-causing nature. Conservation and solvent accessibility analysis of MBP identified three nsSNPs, rs1971676214 (D173E), rs1242552448 (D173H), and rs772570115 (G176W), located in highly conserved, buried structural residues (Table 8), highlighting their potential functional and structural significance. These positions are essential for maintaining the tertiary structure, and mutations may destabilize MBP folding, disrupt its interaction network and impair biological function. These findings highlight the importance of integrating evolutionary conservation and structural context when evaluating the impact of nsSNPs on MBP and associated neurological disorders. AlphaFold model suggests that residues D173 and G176 lie in regions with relatively high local confidence (pLDDT ≈ 76–79), providing a reasonably defined backbone and side-chain environment for these positions (Fig 7). ConSurf scores of 9 indicate that these buried residues are highly conserved, consistent with the idea that even conservative substitutions at these sites may perturb local packing and longer-range structural organization. However, MBP has an intrinsically disordered nature, the AlphaFold model should be viewed as a plausible conformational ensemble rather than a fixed native structure, and any inferred local effects of the D173E, D173H, and G176W substitutions remain hypothesis-generating rather than definitive The result of DDMut analysis provides mechanistic insight by demonstrating that D173E and G176W but not D173H are likely to alter local hydrogen bonds and the ionic contacts (Fig 9). This pattern suggests that not all predicted destabilizing nsSNPs act through the same mechanisms and that some variants may affect packing or hydrophobic interactions rather than hydrogen bonding. STRING-based analysis revealed MBP as a central hub interacting with proteins involved in myelin formation, neural development, and immune regulation (Fig 10). Interactions with immune-related proteins, including MHC class II and CD4, underscore MBP’s immunogenic potential in autoimmune conditions, including multiple sclerosis.
Enrichment analysis indicated that biological regulation (Fig 11A) and protein binding (Fig 11B) are the most prominent functional categories, while KEGG pathways highlighted immune-related signaling, including RIG-I-like receptor and cytokine–cytokine receptor interactions (Fig 11C), relevant to CNS immune responses. Disease-gene analysis linked MBP-associated proteins to the nervous system and autoimmune disorders (Fig 11D), supporting its established role as a major autoantigen in MS and its involvement in neurodegenerative pathways. These findings emphasize MBP’s dual role in structural maintenance and immune-mediated neural processes. Importantly, none of the eight UTR SNPs or the three nsSNPs are documented in the ClinVar database, nor have they been reported in peer-reviewed literature to date, indicating that they may represent novel variants. All predictive algorithms consistently classify these substitutions as potentially deleterious, identifying them as strong candidates for future functional studies and experimental validation. Conclusion Our study provides insight into the effect of both noncoding and coding nsSNPs on the MBP gene, its protein 3D structure, and function. This study might be helpful in future studies of MBP to better understand its role in immunity, especially in MS. This study was carried out using computational tools and web-based servers. Given that all predictive algorithms consistently classify these variants as potentially deleterious, they constitute strong candidates for future functional characterization and epidemiological and experimental validation and do not provide evidence of clinical causality. Biophysical stability studies and T-cell epitope mapping studies with D173E, D173H, and G176W- MBP will play a crucial role in validating the computational results.
Supporting information
S1 Table. List of MBP 3′ UTR SNPs retrieved from NCBI.
This table presents the 3′ UTR SNPs evaluated in this study.
https://doi.org/10.1371/journal.pone.0347598.s001
(XLSX)
S2 Table. List of nsSNPs identified in the MBP gene.
This table presents nsSNPs subjected to functional analysis.
https://doi.org/10.1371/journal.pone.0347598.s002
(XLSX)
S3.1 Table. RegulomeDB scoring of MBP 3′ UTR SNPs.
Regulatory scores for MBP 3′ UTR SNPs (SNP 1–135).
https://doi.org/10.1371/journal.pone.0347598.s003
(XLSX)
S3.2 Table. RegulomeDB scoring of MBP 3′ UTR SNPs.
Regulatory scores for MBP 3′ UTR SNPs (SNP 136–247).
https://doi.org/10.1371/journal.pone.0347598.s004
(XLSX)
S3.3 Table. RegulomeDB scoring of MBP 3′ UTR SNPs.
Regulatory scores for MBP 3′ UTR SNPs (SNP 248–356).
https://doi.org/10.1371/journal.pone.0347598.s005
(XLSX)
S3.4 Table. RegulomeDB scoring of MBP 3′ UTR SNPs.
Regulatory scores for MBP 3′ UTR SNPs (SNP 357–446).
https://doi.org/10.1371/journal.pone.0347598.s006
(XLSX)
S3.5 Table. RegulomeDB scoring of MBP 3′ UTR SNPs.
Regulatory scores for MBP 3′ UTR SNPs (SNP 447–517).
https://doi.org/10.1371/journal.pone.0347598.s007
(XLSX)
S3.6 Table. RegulomeDB scoring of MBP 3′ UTR SNPs.
Regulatory scores for MBP 3′ UTR SNPs (SNP 518–600).
https://doi.org/10.1371/journal.pone.0347598.s008
(XLSX)
S3.7 Table. RegulomeDB scoring of MBP 3′ UTR SNPs.
Regulatory scores for MBP 3′ UTR SNPs (SNP 601–692).
https://doi.org/10.1371/journal.pone.0347598.s009
(XLSX)
S3.8 Table. RegulomeDB scoring of MBP 3′ UTR SNPs.
Regulatory scores for MBP 3′ UTR SNPs (SNP 693–788).
https://doi.org/10.1371/journal.pone.0347598.s010
(XLSX)
S3.9 Table. RegulomeDB scoring of MBP 3′ UTR SNPs.
Regulatory scores for MBP 3′ UTR SNPs (SNP 789–884).
https://doi.org/10.1371/journal.pone.0347598.s011
(XLSX)
S3.10 Table. RegulomeDB scoring of MBP 3′ UTR SNPs.
Regulatory scores for MBP 3′ UTR SNPs (SNP 885–971).
https://doi.org/10.1371/journal.pone.0347598.s012
(XLSX)
S3.11 Table. RegulomeDB scoring of MBP 3′ UTR SNPs.
Regulatory scores for MBP 3′ UTR SNPs (SNP 972–1065).
https://doi.org/10.1371/journal.pone.0347598.s013
(XLSX)
S3.12 Table. RegulomeDB scoring of MBP 3′ UTR SNPs.
Regulatory scores for MBP 3′ UTR SNPs (SNP 1066–1155).
https://doi.org/10.1371/journal.pone.0347598.s014
(XLSX)
S3.13 Table. RegulomeDB scoring of MBP 3′ UTR SNPs.
Regulatory scores for MBP 3′ UTR SNPs (SNP 1156–1236).
https://doi.org/10.1371/journal.pone.0347598.s015
(XLSX)
S3.14 Table. RegulomeDB scoring of MBP 3′ UTR SNPs.
Regulatory scores for MBP 3′UTR SNPs (SNP 1237–1286).
https://doi.org/10.1371/journal.pone.0347598.s016
(XLSX)
S4 Table. PolymiRTS analysis of MBP 3′ UTR SNPs.
Predicted effects of SNPs on miRNA binding sites.
https://doi.org/10.1371/journal.pone.0347598.s017
(XLSX)
S5 Table. SIFT prediction results for MBP nsSNPs.
This table reports the functional impact predictions generated by SIFT, identifying nsSNPs classified as deleterious or tolerated based on the SIFT Tolerance Index.
https://doi.org/10.1371/journal.pone.0347598.s018
(XLSX)
S6 Table. PolyPhen-2 prediction results for MBP nsSNPs.
This table presents PolyPhen-2 predictions for MBP nsSNPs, classifying variants as benign, possibly damaging, or probably damaging based on the PolyPhen-2 score.
https://doi.org/10.1371/journal.pone.0347598.s019
(XLSX)
S7 Table. nsSNPs predicted as deleterious by multiple tools.
This table includes nsSNPs that are consistently classified as damaging by SIFT, PolyPhen-2, and PROVEAN, independent functional prediction tools.
https://doi.org/10.1371/journal.pone.0347598.s020
(XLSX)
S8 Table. META-SNP predictions for MBP nsSNPs.
This table presents the integrated pathogenicity assessment of MBP nsSNPs.
https://doi.org/10.1371/journal.pone.0347598.s021
(XLSX)
S9 Table. ESNPs&GO prediction results for MBP nsSNPs.
This table summarizes disease associations and their reliability using ESNP&GO, with the reliability index.
https://doi.org/10.1371/journal.pone.0347598.s022
(XLSX)
S10 Table. Population allele frequency and clinical annotation of MBP nsSNPs.
This table shows global allele frequencies and functional annotations for prioritized MBP nsSNPs.
https://doi.org/10.1371/journal.pone.0347598.s023
(XLSX)
S11 Table. Predicted effects of MBP nsSNPs on hydrogen bonding using DDMut.
This table shows predicted changes in hydrogen bond interactions.(PDB).
https://doi.org/10.1371/journal.pone.0347598.s024
(XLSX)
S1 File. Structure file for the wild type MBP.
This is a PDB structure file of the MBP using AlphaFold.
https://doi.org/10.1371/journal.pone.0347598.s025
(PDB)
S2 File. Structure file for D173E variant.
This file shows the PDB structure of the D173E mutant protein.
https://doi.org/10.1371/journal.pone.0347598.s026
(PDB)
S3 File. Structure file for D173H variant.
This file shows the PDB structure of the D173H mutant protein.
https://doi.org/10.1371/journal.pone.0347598.s027
(PDB)
S4 File. Structure file for G176Wvariant.
This file shows the PDB structure of the G176W mutant protein.
https://doi.org/10.1371/journal.pone.0347598.s028
(PDB)
References
- 1. Boggs JM. Myelin basic protein: a multifunctional protein. Cell Mol Life Sci. 2006;63(17):1945–61. pmid:16794783
- 2. Harauz G, Ishiyama N, Hill CMD, Bates IR, Libich DS, Farès C. Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis. Micron. 2004;35(7):503–42. pmid:15219899
- 3. Paez PM, Fulton DJ, Spreuer V, Handley V, Campagnoni CW, Macklin WB, et al. Golli myelin basic proteins regulate oligodendroglial progenitor cell migration through voltage-gated Ca2+ influx. J Neurosci. 2009;29(20):6663–76. pmid:19458236
- 4. Wucherpfennig KW, Catz I, Hausmann S, Strominger JL, Steinman L, Warren KG. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. J Clin Invest. 1997;100(5):1114–22. pmid:9276728
- 5. de Ferra F, Engh H, Hudson L, Kamholz J, Puckett C, Molineaux S, et al. Alternative splicing accounts for the four forms of myelin basic protein. Cell. 1985;43(3 Pt 2):721–7. pmid:2416470
- 6. Campagnoni AT, Pribyl TM, Campagnoni CW, Kampf K, Amur-Umarjee S, Landry CF, et al. Structure and developmental regulation of Golli-mbp, a 105-kilobase gene that encompasses the myelin basic protein gene and is expressed in cells in the oligodendrocyte lineage in the brain. J Biol Chem. 1993;268(7):4930–8. pmid:7680345
- 7. Feng J-M, Hu YK, Xie L-H, Colwell CS, Shao XM, Sun X-P, et al. Golli protein negatively regulates store depletion-induced calcium influx in T cells. Immunity. 2006;24: 717–727.
- 8. Zhou Y, Simpson S, Charlesworth JC, van der Mei I, Lucas RM, Ponsonby A-L, et al. Variation within MBP gene predicts disease course in multiple sclerosis. Brain Behav. 2017;7: e00670.
- 9. Martinsen V, Kursula P. Multiple sclerosis and myelin basic protein: insights into protein disorder and disease. Amino Acids. 2022;54(1):99–109. pmid:34889995
- 10. Mayr C. Regulation by 3’-Untranslated Regions. Annu Rev Genet. 2017;51:171–94. pmid:28853924
- 11. Rao SJ, Chatterjee S, Pal JK. Untranslated regions of mRNA and their role in regulation of gene expression in protozoan parasites. J Biosci. 2017;42(1):189–207. pmid:28229978
- 12. Hughes TA. Regulation of gene expression by alternative untranslated regions. Trends Genet. 2006;22(3):119–22. pmid:16430990
- 13. Laursen LS, Chan CW, Ffrench-Constant C. Translation of myelin basic protein mRNA in oligodendrocytes is regulated by integrin activation and hnRNP-K. J Cell Biol. 2011;192(5):797–811. pmid:21357748
- 14. Collins FS, Brooks LD, Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res. 1998;8(12):1229–31. pmid:9872978
- 15. Kamal E, Kaddam LA, Ahmed M, Alabdulkarim A. Integrating Artificial Intelligence and Bioinformatics Methods to Identify Disruptive STAT1 Variants Impacting Protein Stability and Function. Genes (Basel). 2025;16(3):303. pmid:40149454
- 16. Capriotti E, Calabrese R, Casadio R. Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information. Bioinformatics. 2006;22(22):2729–34. pmid:16895930
- 17. GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369(6509):1318–30. pmid:32913098
- 18. UniProt Consortium. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023;51(D1):D523–31. pmid:36408920
- 19. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22:1790–1797.
- 20. Dong S, Zhao N, Spragins E, Kagda MS, Li M, Assis P, et al. Annotating and prioritizing human non-coding variants with RegulomeDB v.2. Nat Genet. 2023;55:724–726.
- 21. Wang J, Li S, Li X, Liu J, Yang J, Li Y, et al. Functional variant rs2270363 on 16p13.3 confers schizophrenia risk by regulating NMRAL1. Brain. 2022;145: 2569–2585.
- 22. Bhattacharya A, Ziebarth JD, Cui Y. PolymiRTS Database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways. Nucleic Acids Res. 2014;42(Database issue):D86–91. pmid:24163105
- 23. Gruber AR, Bernhart SH, Lorenz R. The ViennaRNA web services. Methods Mol Biol. 2015;1269:307–26. pmid:25577387
- 24. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31(13):3812–4. pmid:12824425
- 25. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073–81. pmid:19561590
- 26. Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Current Protocols in Human Genetics. 2013:Unit7.20.
- 27. Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31(16):2745–7. pmid:25851949
- 28. Capriotti E, Altman RB, Bromberg Y. Collective judgment predicts disease-associated single nucleotide variants. BMC Genomics. 2013;14 Suppl 3(Suppl 3):S2. pmid:23819846
- 29. Manfredi M, Savojardo C, Martelli PL, Casadio R. E-SNPs&GO: embedding of protein sequence and function improves the annotation of human pathogenic variants. Bioinformatics. 2022;38(23):5168–74. pmid:36227117
- 30. Mi H, Muruganujan A, Thomas PD. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 2013;41(Database issue):D377–86. pmid:23193289
- 31. Cheng J, Novati G, Pan J, Bycroft C, Žemgulytė A, Applebaum T, et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science. 2023;381(6664):eadg7492. pmid:37733863
- 32. Capriotti E, Fariselli PF, Calabrese R, Casadio R. Predicting protein stability changes from sequences using support vector machines. Bioinformatics. 2005;21(Suppl 2):ii54–8.
- 33. Cheng J, Randall A, Baldi P. Prediction of protein stability changes for single-site mutations using support vector machines. Proteins. 2006;62(4):1125–32. pmid:16372356
- 34. Zhou Y, Pan Q, Pires DEV, Rodrigues CHM, Ascher DB. DDMut: predicting effects of mutations on protein stability using deep learning. Nucleic Acids Res. 2023;51(W1):W122–8. pmid:37283042
- 35. Ashkenazy H, Erez E, Martz E, Pupko T, Ben-Tal N. ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res. 2010;38(Web Server issue):W529–33. pmid:20478830
- 36. Varadi M, Anyango S, Deshpande M, Nair S, Natassia C, Yordanova G, et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 2022;50(D1):D439–44. pmid:34791371
- 37. Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638–46. pmid:36370105
- 38. Gudmundsson S, Singer-Berk M, Watts NA, Phu W, Goodrich JK, Solomonson M, et al. Variant interpretation using population databases: Lessons from gnomAD. Hum Mutat. 2022;43(8):1012–30. pmid:34859531
- 39. Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42(Database issue):D980–5. pmid:24234437
- 40. Meng EC, Goddard TD, Pettersen EF, Couch GS, Pearson ZJ, Morris JH. UCSF ChimeraX: Tools for structure building and analysis. Protein Sci. 2023;32:e4792.
- 41. Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605–12. pmid:33237311
- 42. Zecević N, Andjelković A, Matthieu JM, Tosić M. Myelin basic protein immunoreactivity in the human embryonic CNS. Brain Res Dev Brain Res. 1998;105(1):97–108. pmid:9497084
- 43. Chignola R, Cestari T, Guerriero C, Riviera AP, Ferrari S, Brendolan A, et al. Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies. Clin Exp Immunol. 2000;122(3):429–36. pmid:11122251